BioCentury
ARTICLE | Company News

Nuron, Vitruvian Biomedical deal

April 16, 2012 7:00 AM UTC

Vitruvian granted Nuron exclusive, worldwide rights to develop and commercialize Vitruvian's AB42 vaccine, a DNA vaccine containing a gene fragment that codes for beta amyloid 42. The vaccine is in ...